Skip to main content
Wendy Pang, MD, Oncology, Stanford, CA

WendyPangMDPhD

Oncology Stanford, CA

Hematologic Oncology

Physician

Dr. Pang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pang's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    # Grant
    Stanford, CA 94305
    Phone+1 650-723-6661
    Fax+1 650-498-6205

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2014 - 2018
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2012 - 2014
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Press Mentions

  • Jasper Therapeutics Initiates New Clinical Trial with National Cancer Institute to Evaluate JSP191 in GATA2-Related Myelodysplastic Syndromes
    Jasper Therapeutics Initiates New Clinical Trial with National Cancer Institute to Evaluate JSP191 in GATA2-Related Myelodysplastic SyndromesSeptember 8th, 2021
  • Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation
    Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell TransplantationFebruary 8th, 2021
  • Antibody Could Increase Cure Rate for Blood, Immune Disorders
    Antibody Could Increase Cure Rate for Blood, Immune DisordersFebruary 11th, 2019